1:00 pm – 1:30 pm PDT Breathing Innovation: Inhaled Pirfenidone for the Treatment of Progressive Pulmonary Fibrosis
1:00 pm – 1:45 pm PDT Featured Featured Understanding the Pathophysiology and Burden of COPD With Blood Eosinophils as a Marker of T2 Inflammation – Is it the Time for Precision Medicine in COPD?
1:00 pm – 2:00 pm PDT Featured Featured Clinical Considerations for Sleep Specialists on the Improvement of Wakefulness in Patients With Excessive Daytime Sleepiness
1:15 pm – 1:35 pm PDT The Healthcare of Today, Looking towards Tomorrow: Digital Innovations and Patient-Centricity
1:15 pm – 2:00 pm PDT COPD and Asthma with Type 2 Inflammation: Distinct Diseases with a Shared Cause
6:30 pm – 7:30 pm PDT Featured Featured Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?
6:30 pm – 9:30 pm PDT An Expert Panel on Severe Asthma: From the Epithelium to Better Patient Outcomes
6:30 pm – 9:30 pm PDT Applying Newer Diagnostic and Therapeutic Tools to the Management of the Individual with Nontuberculous Mycobacterial Lung Disease
11:35 am – 11:55 am PDT Postoperative Prolonged Air Leaks with the Spiration Valve System, Roy Cho, MD
12:00 pm – 12:30 pm PDT Featured Featured Holistic Care of the Immunocompromised Pulmonary Patient with EGPA
12:35 pm – 12:55 pm PDT The heterogeneity of COPD pathophysiology and the role of PDE inhibition: focus on mucociliary dysfunction
1:15 pm – 2:15 pm PDT Global Health Inequities in Chronic Respiratory Disease: Challenges and Potential Solutions
1:30 pm – 2:15 pm PDT Machine Learning and Fibrosing Lung Disease: Imaging Biomarker Progress – with Dr. Simon Walsh and Dr. Kevin Brown, moderated by Elizabeth Estes
6:30 pm – 9:30 pm PDT Surv.AI Says: Real-World Insights into the Journey for Patients with Pulmonary Arterial Hypertension